Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oumou Bah-Sow

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|May 20, 2006
Pulmonary tuberculosis: diagnosis and treatmentIan A Campbell, Oumou Bah-Sow
The Journal of Antimicrobial Chemotherapy|September 22, 2018
Effect of efavirenz-based antiretroviral therapy and high-dose rifampicin on the pharmacokinetics of isoniazid and acetyl-isoniazidMaxwell T Chirehwa, Helen McIlleron, Lubbe Wiesner, et al.
Multidisciplinary Respiratory Medicine|September 24, 2021
Tuberculosis prevalence and associated factors among persons with diabetes mellitus after intensified case finding in three West African countriesAblo Prudence Wachinou, Serge Ade, Maimouna Ndour Mbaye, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Evaluation of initial and steady-state gatifloxacin pharmacokinetics and dose in pulmonary tuberculosis patients by using monte carlo simulationsWynand Smythe, Corinne S Merle, Roxana Rustomjee, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patientsWynand Smythe, Akash Khandelwal, Corinne Merle, et al.
Trials|May 22, 2012
A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) projectCorinne S C Merle, Charalambos Sismanidis, Oumou Bah Sow, et al.
Multidisciplinary Respiratory Medicine|May 9, 2025
Tuberculosis prevalence and associated factors among persons infected with human immunodeficiency virus in three West African countries -(Benin, Guinea, Senegal)Ablo Prudence Wachinou, Boubacar Bah, Fatou Ndeye Ngom, et al.
Immunogenetics|September 5, 2003
Variants of the CD40 ligand gene are not associated with increased susceptibility to tuberculosis in West AfricaSarah J Campbell, Pardis Sabeti, Katherine Fielding, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2006
Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West AfricaKerrie Tosh, Sarah J Campbell, Katherine Fielding, et al.
Lancet (London, England)|November 13, 2014
Randomised controlled trials for Ebola: practical and ethical issuesClement Adebamowo, Oumou Bah-Sow, Fred Binka, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|May 20, 2006
Pulmonary tuberculosis: diagnosis and treatmentIan A Campbell, Oumou Bah-Sow
The Journal of Antimicrobial Chemotherapy|September 22, 2018
Effect of efavirenz-based antiretroviral therapy and high-dose rifampicin on the pharmacokinetics of isoniazid and acetyl-isoniazidMaxwell T Chirehwa, Helen McIlleron, Lubbe Wiesner, et al.
Multidisciplinary Respiratory Medicine|September 24, 2021
Tuberculosis prevalence and associated factors among persons with diabetes mellitus after intensified case finding in three West African countriesAblo Prudence Wachinou, Serge Ade, Maimouna Ndour Mbaye, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Evaluation of initial and steady-state gatifloxacin pharmacokinetics and dose in pulmonary tuberculosis patients by using monte carlo simulationsWynand Smythe, Corinne S Merle, Roxana Rustomjee, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patientsWynand Smythe, Akash Khandelwal, Corinne Merle, et al.
Trials|May 22, 2012
A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) projectCorinne S C Merle, Charalambos Sismanidis, Oumou Bah Sow, et al.
Multidisciplinary Respiratory Medicine|May 9, 2025
Tuberculosis prevalence and associated factors among persons infected with human immunodeficiency virus in three West African countries -(Benin, Guinea, Senegal)Ablo Prudence Wachinou, Boubacar Bah, Fatou Ndeye Ngom, et al.
Immunogenetics|September 5, 2003
Variants of the CD40 ligand gene are not associated with increased susceptibility to tuberculosis in West AfricaSarah J Campbell, Pardis Sabeti, Katherine Fielding, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2006
Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West AfricaKerrie Tosh, Sarah J Campbell, Katherine Fielding, et al.
Lancet (London, England)|November 13, 2014
Randomised controlled trials for Ebola: practical and ethical issuesClement Adebamowo, Oumou Bah-Sow, Fred Binka, et al.
Pageof 2